Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Eliem Therapeutics Inc

(NASDAQ: ELYM)
Add to Portfolio
+0.05 (+0.65%)
as of May 31, 2024

Values in US Thousands
  12-2023 12-2022 12-2021 12-2020
Operating Expenses 40,275 45,135 35,672 20,925
Operating Income -40,275 -45,135 -35,672 -20,925
Other Income/Expenses 5,156 -109 -11,808 257
Pre-tax Income -35,119 -45,244 -47,480 -20,668
Net Income from Cont. Operations -35,119 -45,244 -47,480 -20,668
Total Net Income $ -35,119 $ -45,244 $ -47,480 $ -20,668
Basic EPS from Cont. Ops. -1.30 -1.72 -3.87 -9.45
Basic EPS from Total Ops. -1.30 -1.72 -4.24 -10.49
Diluted EPS from Cont. Ops -1.30 -1.72 -3.87 -9.45
Diluted EPS from Total Operations -1.30 -1.72 -4.24 -10.49
EBITDA -42,606 -45,312 -35,302 -20,925